trimetazidine has been researched along with Diabetes Mellitus in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 5 (38.46) | 2.80 |
| Authors | Studies |
|---|---|
| Brooks, GA; Kerr, D; Klonoff, DC; Mehta, C; Nguyen, KT; Umpierrez, GE; Xu, NY | 1 |
| Liang, Y; Ren, K; Xu, XD; Zhao, GJ | 1 |
| Fu, N; Li, W; Men, X; Yang, S; Zhang, P; Zhang, X | 1 |
| Duan, Y; Lin, Y; Sun, ZQ; Wang, ZL; Yan, M; Zhu, FY | 1 |
| Mahajan, AU; Mahajan, S | 1 |
| Chen, S; Lin, H; Wu, K; Zhang, J; Zhang, W | 1 |
| Ambrosio, G; Grant, PJ; Tamargo, J | 1 |
| Chen, C; Li, YJ; Wang, DW; Wang, PH; Zou, MH | 1 |
| Qizhu, T; Wenmeng, W | 1 |
| Marzilli, M; Stanley, WC | 1 |
| Galaris, D; Korantzopoulos, P; Kountouris, E; Siogas, K | 1 |
| Fragasso, G; Rosano, GM; Vitale, C | 1 |
| Celik, T; Iyisoy, A; Jata, B; Kursaklioglu, H | 1 |
5 review(s) available for trimetazidine and Diabetes Mellitus
| Article | Year |
|---|---|
Effect of Trimetazidine on Diabetic Patients with Coronary Heart Diseases: A Meta-Analysis of Randomized, Controlled Trials.
Topics: Blood Glucose; Coronary Disease; Diabetes Mellitus; Diastole; Exercise Tolerance; Humans; Myocardial Ischemia; Randomized Controlled Trials as Topic; Trimetazidine; Ventricular Function, Left | 2020 |
Current Clinical Evidence of Trimetazidine in the Management of Heart Disease in Patients with Diabetes.
Topics: Coronary Artery Disease; Diabetes Mellitus; Humans; Myocardial Ischemia; Trimetazidine; Vasodilator Agents | 2020 |
Non-haemodynamic anti-anginal agents in the management of patients with stable coronary artery disease and diabetes: A review of the evidence.
Topics: Animals; Cardiovascular Agents; Coronary Artery Disease; Diabetes Mellitus; Humans; Ranolazine; Trimetazidine; Vasodilator Agents | 2016 |
Metabolic therapy in the treatment of ischaemic heart disease: the pharmacology of trimetazidine.
Topics: Angina Pectoris; Carbohydrate Metabolism; Diabetes Complications; Diabetes Mellitus; Energy Metabolism; Fatty Acids; Humans; Myocardial Ischemia; Myocardium; Trimetazidine; Vasodilator Agents; Ventricular Dysfunction, Left | 2003 |
Metabolic therapy for patients with diabetes mellitus and coronary artery disease.
Topics: Coronary Disease; Diabetes Mellitus; Fatty Acids, Nonesterified; Humans; Muscle, Skeletal; Myocardium; Treatment Outcome; Trimetazidine; Vasodilator Agents; Ventricular Function, Left | 2006 |
1 trial(s) available for trimetazidine and Diabetes Mellitus
| Article | Year |
|---|---|
Preventive effect of trimetazidine on contrast-induced nephropathy undergoing percutaneous coronary intervention in elderly moderate and high risk diabetics stratified by mehran score.
Topics: Aged; Contrast Media; Coronary Angiography; Creatinine; Diabetes Mellitus; Humans; Kidney Diseases; Percutaneous Coronary Intervention; Risk Factors; Trimetazidine | 2021 |
7 other study(ies) available for trimetazidine and Diabetes Mellitus
| Article | Year |
|---|---|
Trimetazidine Blocks Lipid Oxidation-Should it be Repurposed for Prevention and Treatment of Diabetic Ketoacidosis?
Topics: Blood Glucose; Diabetes Mellitus; Diabetic Ketoacidosis; Humans; Lipids; Trimetazidine | 2022 |
Trimetazidine attenuates diabetic inflammation via Nrf2 activation.
Topics: Diabetes Mellitus; Humans; Inflammation; NF-E2-Related Factor 2; Trimetazidine; Vasodilator Agents | 2020 |
Effect of Trimetazidine on Preventing Contrast-Induced Acute Kidney Injury in Patients With Diabetes.
Topics: Acute Kidney Injury; Coronary Angiography; Diabetes Mellitus; Humans; Trimetazidine | 2018 |
Improvement of mechanical heart function by trimetazidine in db/db mice.
Topics: AMP-Activated Protein Kinases; Animals; Antioxidants; Diabetes Complications; Diabetes Mellitus; Fats; Heart; Lipid Peroxidation; Male; Mice; Mice, Inbred C57BL; Myocardium; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Reactive Oxygen Species; Trans-Activators; Transcription Factors; Triglycerides; Trimetazidine | 2010 |
Early administration of trimetazidine may prevent or ameliorate diabetic cardiomyopathy.
Topics: Animals; Diabetes Mellitus; Diabetic Cardiomyopathies; Heart Failure; Humans; Male; Mice; Mice, Inbred C57BL; Models, Theoretical; Myocardial Ischemia; Myocardium; Research Design; Risk Factors; Treatment Outcome; Trimetazidine; Vasodilator Agents | 2011 |
The potential benefits of trimetazidine in patients with diabetes and ischemic cardiomyopathy.
Topics: Anti-Arrhythmia Agents; Antioxidants; Diabetes Complications; Diabetes Mellitus; Fatty Acids; Humans; Myocardial Ischemia; Oxidation-Reduction; Oxidative Stress; Trimetazidine; Vasodilator Agents | 2004 |
Metabolic agents in the management of diabetic coronary patients: a new era.
Topics: Carnitine; Coronary Disease; Diabetes Mellitus; Diabetic Angiopathies; Dichloroacetic Acid; Enzyme Inhibitors; Epoxy Compounds; Humans; Perhexiline; Trimetazidine; Vasodilator Agents; Vitamin B Complex | 2008 |